Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04085965 · ClinicalTrials.gov registry record · NA

Testing the Feasibility and Preliminary Effect of Summer Camp

A NA study, sponsored by The Miriam Hospital.

Completed
Registry status
NA
Development phase
94
Enrollment target

NCT04085965: Completed NA study, sponsored by The Miriam Hospital.

NCT04085965 is a NA study that has completed, run by The Miriam Hospital. The registered enrollment target is 94 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04085965, a NA study, has completed, sponsored by The Miriam Hospital.

COMPLETED
Registry status
NA
Development phase
94 participants
Enrollment target

Study Summary

This pilot randomized controlled trial was designed to assess the feasibility and preliminary efficacy of randomizing children, ages 6-12 years from two low-income communities in Rhode Island, to attend a summer day camp (CAMP) or to experience summer as usual (SAU). Children randomized to CAMP attended a Boys and Girls Club summer day camp for 8-weeks in summer 2017 or 2018. As part of the consent process, children randomized to SAU agreed to experience an unstructured summer (i.e. not enroll in more than one week of summer camp, summer school or other structured summer programming). Primary feasibility outcomes included retention, engagement and completion of midsummer measures. Secondary outcomes, change in BMIz (a proxy for excess summer weight gain), physical activity engagement, sedentary behavior, and diet (energy intake and diet quality), were collected by blinded research staff at the end of the school year, midsummer and the end of the summer.

Primary Outcome

Number of participants who completed both baseline and end of summer assessments

Interventions

  • BEHAVIORAL Boys and Girls Club summer day camp

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2017-05-17
Est. Completion 2018-08-22
Phase NA
The Miriam Hospital

136 total trials

What the finished NCT04085965 record still lists

NCT04085965 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 1 intervention - of which Boys and Girls Club summer day camp is the first listed.

NCT04085965 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04085965 about?

NCT04085965 is a clinical study titled "Testing the Feasibility and Preliminary Effect of Summer Camp". This pilot randomized controlled trial was designed to assess the feasibility and preliminary efficacy of randomizing children, ages 6-12 years from two low-income communities in Rhode Island, to attend a summer day camp (CAMP) or to experience summer as usual (SAU). Children randomized to CAMP atte...

What is the current status of trial NCT04085965?

This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2017-05-17. Estimated completion is 2018-08-22.

What interventions are being tested in trial NCT04085965?

The interventions under investigation include: Boys and Girls Club summer day camp (BEHAVIORAL).

Who is sponsoring clinical trial NCT04085965?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04085965's enrollment target sits among peer trials

94 935th of 2000 higher than 1,064 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03747146 · 94 participants · NA

    Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service

  • NCT04061421 · 94 participants · Phase 1

    Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)

  • NCT04205968 · 94 participants · Phase 2

    Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

  • NCT04464759 · 94 participants · Phase 1

    A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04085965, the US trial registry maintained by the National Library of Medicine. NCT04085965 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.